| Literature DB >> 35743555 |
Xuejun He1, Ningzhi Zhang1, Wenye Cao1, Yiqiao Xing1,2, Ning Yang1.
Abstract
Ocular diseases affect multiple eye parts and can be caused by pathogenic infections, complications of systemic diseases, genetics, environment, and old age. Understanding the etiology and pathogenesis of eye diseases and improving their diagnosis and treatment are critical for preventing any adverse consequences of these diseases. Recently, the advancement of high-throughput sequencing (HTS) technology has paved wide prospects for identifying the pathogenesis, signaling pathways, and biomarkers involved in eye diseases. Due to the advantages of HTS in nucleic acid sequence recognition, HTS has not only identified several normal ocular surface microorganisms but has also discovered many pathogenic bacteria, fungi, parasites, and viruses associated with eye diseases, including rare pathogens that were previously difficult to identify. At present, HTS can directly sequence RNA, which will promote research on the occurrence, development, and underlying mechanism of eye diseases. Although HTS has certain limitations, including low effectiveness, contamination, and high cost, it is still superior to traditional diagnostic methods for its efficient and comprehensive diagnosis of ocular diseases. This review summarizes the progress of the application of HTS in ocular diseases, intending to explore the pathogenesis of eye diseases and improve their diagnosis.Entities:
Keywords: biomarkers; high-throughput sequencing; microRNA; next-generation sequencing; ocular disease
Year: 2022 PMID: 35743555 PMCID: PMC9225376 DOI: 10.3390/jcm11123485
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Ocular microbes identified using high-throughput sequencing.
| Term | Bacteria | Fungal | Virus | Parasite | Sample | References |
|---|---|---|---|---|---|---|
| MiSeq Illumina |
|
| — | — | Conjunctival swab samples | [ |
| GS-FLX 454 |
| — | — | — | Conjunctival swab samples | [ |
| Metagenomic deep sequencing | — | Cryptococcus neoformans | Human adenovirus, Herpes simplex virus, Rubella virus, Epstein-Barr virus, Human herpesvirus 8 |
| Conjunctival swab samples, Intraocular fluid samples, Aqueous fluid | [ |
| Illumina HiSeq 750 |
| — | Torque Teno Virus | — | Aqueous fluid, Vitreous samples | [ |
| Next-generation sequencing |
|
| Pseudorabies virus, Suid herpesvirus 1, Bovine herpesvirus 5 | — | Vitreous humor | [ |
Differentially expressed miRNAs in intraocular diseases identified by high-throughput sequencing.
| Term | miRNA | Ocular Disease | Sample | References |
|---|---|---|---|---|
| HiSeq4000 platform | ↑: hsa-miR-99b-5p | PDR | Aqueous humor | [ |
| HiSeq4000 platform | ↑: hsa-miR-205-5p, hsa-miR-206, hsa-miR-16-5p, hsa-miR-501-3p, hsa-miR-409-3p, hsa-miR-200a-3p, hsa-miR-200b-3p, hsa-miR-382-5p, hsa-miR-543, hsa-miR-136-3p, hsa-miR-30c-2-3p, hsa-miR-139-5p, hsa-miR-340-5p, hsa-miR-488-3p, hsa-miR-202-5p, hsa-miR-369-5p | POAG | Aqueous humor | [ |
| HiSeq4000 platform | ↑: hsa-miR-885-5p, hsa-miR-210-3p, hsa-miR-3149 | POAG | Aqueous humor | [ |
| Illumina NovaSeq 6000 | ↑: Hsa-miR-30a-3p, hsa-miR-143-3p, hsa-miR-211-5p, hsa-miR221-3p | POAG | Aqueous humor | [ |
| NextSeq500 system | ↑: hsa-let-7a-5p, hsa-let-7c-5p, hsa-let-7f-5p, hsa-miR-192-5p, hsa-miR-10a-5p, hsa-miR-10b-5p, hsa-miR-375, and hsa-miR-143-3p | NTG | Aqueous humor | [ |
| Illumina HiSeq4000 | ↑: miR-29b, let7b/c/e, miR-214, miR-103, miR-98 | High myopia | Aqueous humor | [ |
↑, upregulated; ↓, downregulated; hsa, Homo sapiens species; miR, microRNA; PDR, proliferative diabetic retinopathy; POAG, primary open-angle glaucoma; NTG: normal-tension glaucoma.
Comparison of methods to identify the etiology of eye disease.
| Method | Advantages | Limitations | References |
|---|---|---|---|
| Microbial Culture | High specificity. | Time-consuming; | [ |
| Polymerase Chain Reaction | Samples can be expanded indefinitely; | Sample site dependence; | [ |
| Confocal Microscopy | Non-invasive; | Inability to type microbes; | [ |
| High-throughput Sequencing | High positive rate; | Expensive; | [ |